摘要
Mesoporous silica microspheres with a pore-size larger than 10 nm and a large pore-volume have attracted considerable attention for their application
作者Zitong Zhang;Jiahua Meng;Jiaqi Tian;Ning Li;Zhen Chen;Xiang Yun;Dandan Song;Fei Li;Shuyin Duan;Lin Zhang
（
1Clinical Medical Research Center for Women and Children Diseases, Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan 250001, China;School of Public Health, Qingdao University, Qingdao 266071, China;2School of Public Health, North China University of Science and Technology, Tangshan 063000, China;3Clinical Medical Research Center for Women and Children Diseases, Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan 250001, China;Key Laboratory of Birth Defect Prevention and Genetic Medicine of Shandong Health Commission, Jinan 250001, China;4School of Public Health, Shandong Second Medical University, Weifang 261053, China;5School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250001, China;Corresponding author.;6Clinical Medical Research Center for Women and Children Diseases, Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan 250001, China;Key Laboratory of Birth Defect Prevention and Genetic Medicine of Shandong Health Commission, Jinan 250001, China;Correspondence to: Clinical Medical Research Center for Women and Children Diseases, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan 250001, China.
）
出处
Ecotoxicology and Environmental Safety 2024 Vol.286
P117245
摘要
A growing body of evidence exhibits the ubiquitous presence and accumulation of micro- and nanoplastics in the air, drinking water, food, and even in
作者Xiao-Dong Mo;Shen-Da Hong;Yan-Li Zhao;Er-Lie Jiang;Jing Chen;Yang Xu;Zi-Min Sun;Wei-Jie Zhang;Qi-Fa Liu;Dai-Hong Liu;Ding-Ming Wan;Wen-Jian Mo;Han-Yun Ren;Ting Yang;He Huang;Xi Zhang;Xiao-Ning Wang;Xian-Min Song;Su-Jun Gao;Xin Wang;Yi Chen;Bing Xu;Ming Jiang;Xiao-Bing Huang;Xin Li;Hong-Yu Zhang;Hong-Tao Wang;Zhao Wang;Ting Niu;Ji-Shi Wang;Ling-Hui Xia;Xiao-Dan Liu;Fei Li;Fang Zhou;Tao Lang;Jiong Hu;Sui-Jing Wu;Xiao-Jun Huang
（
Affiliations 1 Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. 2 Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences (2019RU029), Beijing, China. 3 National Institute of Health Data Science at Peking University, Peking University Health Science Center, Beijing, China. 4 Hebei Yanda Lu Daopei Hospital, Beijing Lu Daopei Institute of Hematology, Beijing, China. 5 State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China. 6 Department of Hematology and Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 7 National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China. 8 Department of Hematology, the First Affiliated Hospital of University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. 9 Department of Hematology, Aerospace Center Hospital, Beijing, China. 10 Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China. 11 Department of Hematology, Chinese PLA General Hospital, Beijing, China. 12 Department of Hematology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. 13 Department of Hematology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, China. 14 Department of Hematology, Peking University First Hospital, Beijing, China. 15 Fujian Medical University Union Hospital, Fujian Institute of Hematology, Department of Hematology, Fujian Provincial Key Laboratory of Hematology, Fuzhou, China. 16 Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. 17 Medical Center of Hematology, Xinqiao Hospital, Army Medical University; State Key Laboratory of Trauma, Burn and Combined Injury, Chongqing, China. 18 Department of Hematology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. 19 Department of Hematology, Shanghai general Hospital affiliated to Shanghai Jiaotong University, Shanghai, China. 20 Department of Hematology, the First Hospital of Jilin University, Changchun, China. 21 Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China. 22 Department of Hematology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou Key Laboratory of Hematology, Wenzhou, China. 23 The First Affiliated Hospital of Xiamen University, Xiamen University Institute of Hematology, Xiamen, China. 24 Hematologic Disease Center, the First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region Research Institute of Hematology Xinjiang Medical University, Urumqi, China. 25 Department of Hematology, Sichuan Provincial People's Hospital, Affiliated Hospital of University of Electronic Science and Technology of China, Chengdu, China. 26 Department of Hematology, the Third Xiangya Hospital, Central South University, Changsha, China. 27 Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, China. 28 Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China. 29 Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China. 30 Department of Hematology, West China hospital, Sichuan University, Chengdu, China. 31 Guizhou Province Hematopoietic Stem Cell Transplantation Center, Department of Hematology, Key Laboratory of Hematological Disease Diagnostic and Treat Centre of Guizhou Province, The Affiliated Hospital of Guizhou Medical University, Guiyang, China. 32 Division of Bone Marrow Transplantation, Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. 33 Department of Hematology, the Affiliated Hospital of Qingdao University, Qingdao, China. 34 Department of Hematology, the First Affiliated Hospital of Nanchang University, Nanchang, China. 35 Department of Hematology, the 960 Hospital of the PLA Joint Logistics Support Force, Jinan, China. 36 Department of Hematology, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China. 37 Blood and Marrow Transplantation Center, Department of Hematology, Shanghai Institute of Hematology, Collaborative Innovation Center of Hematology, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. 38 Department of Hematology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, School of Medicine, South China University of Technology, Guangzhou, China. 39 Peking-Tsinghua Center for Life Sciences, Beijing, China. 40 Collaborative Innovation Center of Hematology, Peking University, Beijing, China.
）
出处
American journal of hematology 2022 Vol.97 No.4
P458-469
摘要
Steroid-refractory acute graft-versus-host disease is one of the leading causes of early mortality after allogeneic hematopoietic stem cell transpla
作者Tingyu Wang;Xiuhua Sun;Lihua Qiu;Hang Su;Junning Cao;Zhiming Li;Yuqin Song;Li Zhang;Deng'Ju Li;Huijing Wu;Wei Zhang;Junmin Li;Ke-Shu Zhou;Hui Zhou;Yu Yang;Zhifeng Li;Hong Cen;Zhen Cai;Zhihui Zhang;Weijun Fu;Jie Jin;Fei Li;Weixin Wu;Xuekui Gu;Weiliang Zhu;Lihong Liu;Zengjun Li;Shuhua Yi;Hanying Bao;Zusheng Xu;Lugui Qiu
（
Affiliations 1 State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tian Jin, China. 2 The Second Affiliated Hospital of Dalian Medical Universitiy, Dalian, Liaoning, China. 3 Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, China. 4 307 Hospital, Academy of Military Medical Science, Beijing, P. R. China, China. 5 Fudan University Shanghai Cancer Center, Shanghai, China. 6 Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China. 7 Peking University Cancer Hospital & Institute, Beijing, China. 8 Department of Hematology, West China Hospital, Sichuan University, Chengdu, China, Chengdu, China. 9 Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;, Wuhan, Hubei, China. 10 Hubei Cancer Hospital, China. 11 Peking Union Medical College Hospital, Beijing, China. 12 Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China. 13 Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, HeNan, China. 14 The Affiliated Cancer Hospital of XiangYa School of Medicine, Central South University, Changsha, Hunan, China. 15 Fujian Provincial Cancer Hospital, The Affiliated Tumor Hospital of Fujian Medical University, China. 16 Southern Medical University, Xiamen, China. 17 Guangxi Medical University Affiliated Tumor Hospital & Oncology Medical College, China. 18 The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. 19 Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, China. 20 Shanghai Fourth People's Hospital, School of Medicine, Tongji University, shanghai, China. 21 First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China. 22 First Affiliated Hospital of Nanchang University, China. 23 The University of Texas MD Anderson Cancer Center, Houston, TX, United States. 24 First Affiliated Hospital of Guangzhou University of Chinese Medicine, China. 25 Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China, China. 26 Fourth Hospital of Hebei Medical University, Shijiazhuang, China. 27 Department of Hematology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, No. 440, Ji Yan Road, Jinan 250117, China, Jinan, China. 28 National Clinical Research Center for Blood Diseases, Tianjin, China. 29 Shanghai Yingli Pharmaceutical Co., Ltd, China. 30 Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
）
出处
Clinical cancer research : an official journal of the American Association for Cancer Research 2023
摘要
Purpose: To investigate the efficacy and safety of the novel orally active phosphatidylinositol 3-kinase delta inhibitor in relapsed and/or refractor
作者Wang Xue;Zhou Jin;Han Lei;Cheng Xiurong;Shao Hua;Jia Qiang;Xu Peiyu;Liu Jing;Ren Jie;Li Jin;Li Fei;Zhu Baoli;Zhang Meibian;Xing Caihong
（
National Institute for Occupational Health and Poison Control，Chinese Center for Disease Control and Prevention，Key Laboratory of Chemical Safety and Health，Chinese Center for Disease Control and Prevention；Jiangsu Provincial Center for Disease Control and Prevention；Shandong Academy of Occupational Health and Occupational Medicine，Shandong First Medical University & Shandong Academy of Medical Sciences；Department of Nutrition，Food Safety and Toxicology，West China School of Public Health，Sichuan University；Tianjin Centers for Disease Control and Prevention；Fujian Center for Prevention and Control of Occupational Diseases and Chemical Poisoning；Zhejiang Provincial Center for Disease Control and Prevention
）
出处
China CDC Weekly 2021 第3卷 第43期
P897-900
摘要
What is already known about this topic? Benzene is classified as a Class I human carcinogen by the International Agency for Research on Cancer.Long-te
作者Zhen Fang;Wentong Mei;Chang Qu;Jiongdi Lu;Liang Shang;Feng Cao;Fei Li
（
1Department of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China;2Department of Gastrointestinal Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China
）
摘要
The N-methyladenosine modification is the most pervasive modification of human RNAs. In recent years, an increasing number of studies have suggested
作者Li, Fei;Li, Juan;Zhang, Zhenjie;Hou, Lin;Cui, Qinghua;Tian, Jingzhen
（
1 Key Laboratory of Etiology and Epidemiology of Emerging Infectious Diseases, Department of Pharmacy, Shandong First Medical University & Shandong Academy of Medical Sciences, Tai'an, 271016, China; 2 Department of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China
）
出处
Chinese Traditional and Herbal Drugs 2021 Vol.52 No.12
P3576
摘要
Objective: To explore the effect and mechanisms action of Yinhua-Qinghao-Zhizi Enema against coxsackievirus A6 in vivo. Methods: Ten-day-old ICR mic
